Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.
about
Autoimmunity and infection in Sjögren's syndromeHuman T cell leukemia virus type-I and rheumatoid arthritis.High prevalence of arthropathy in HTLV-I carriers on a Japanese island.Lupus nephritis class I accompanied by tubulointerstitial nephritis with marked T-lymphocyte infiltration in an HTLV-1 positive patientCharacterization and sequencing of prototypic human T-lymphotropic virus type 1 (HTLV-1) from an HTLV-1/2 seroindeterminate patient.Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus)Human T-cell lymphotropic virus type 1 tax among American blood donorsIs Sjögren's syndrome a retroviral disease?Hospital admissions for human T-cell lymphotropic virus type-1 (HTLV-1) associated diseases in Dominica.Lamivudine is not effective in primary Sjögren's syndrome.Detection of HTLV-1 by polymerase chain reaction in situ hybridization in adult T-cell leukemia/lymphomaReevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjögren's syndrome.The transposon-driven evolutionary origin and basis of histone deacetylase functions and limitations in disease prevention.Clinical Trials and Treatment of ATL.Inhibitory activity in saliva of cell-to-cell transmission of human T-cell lymphotropic virus type 1 in vitro: evaluation of saliva as an alternative source of transmissionTherapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice.Primary Sjogren's syndrome: too dry and too tired.Implication of human endogenous retroviruses in the development of autoimmune diseases.Neuroimmunological aspects of human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis.Inflammatory manifestations of HTLV-1 and their therapeutic options.Rate of positive autoimmune markers in Human T lymphotropic virus type 1 carriers: a case-control study from Iran.Analysis of the downstream mediators of toll-like receptor 3-induced apoptosis in labial salivary glands in patients with Sjögren's syndrome.Prevalence of human T-cell lymphotropic virus type 1 and 2 among patients with malignant hematological diseases in south Chile.Nucleotide sequence analysis of human T-cell lymphotropic virus type I pX and LTR regions from patients with sicca syndrome.Direct infection of primary salivary gland epithelial cells by human T lymphotropic virus type I in patients with Sjögren's syndrome.Alopecia areata possibly induced by autoimmune reaction in a patient with human T-cell lymphotropic virus-1-associated myelopathy.Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.Discrepancy, coincidence or evidence in chronic idiopathic spastic paraparesis throughout the world. A meta-analysis on 2811 patients.Oral health profile in patients infected with HTLV-1: clinical findings, proviral load, and molecular analysis from HTLV-1 in saliva.Prevalence of Sjögren's syndrome in Brazilian patients infected with human T-cell lymphotropic virus.Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome.HTLV infections among Swedish intravenous drug users in 1992.Amyotrophic lateral sclerosis presentation of a human T-lymphotropic virus type-1 myelopathy--insight into pathogenesis.Cytokine production by endothelial cells infected with human T cell lymphotropic virus type I.Possible association between adult T-cell leukemia/lymphoma and acute myeloid leukemia.Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series.Human T-cell leukemia virus type 1 infection worsens prognosis of hepatitis C virus-related living donor liver transplantation.HTLV-I virological and histopathological analysis in two cases of anti-centromere-antibody-seropositive Sjögren's syndrome.Estradiol represses human T-cell leukemia virus type 1 Tax activation of tumor necrosis factor-alpha gene transcription.Sicca syndrome in patients infected with human immunodeficiency virus-1.
P2860
Q27026174-6F8F1732-6A9A-4A87-A1E3-D3F46D3AFB43Q33536189-547C31DF-5B03-400C-B31D-FAEE0DFC6923Q33578804-F88BCD44-0637-412C-98F7-3159FB64DDEDQ33622071-67427C26-DECA-4B55-857D-DF970B267FF9Q33798532-8F82EA4A-E0B2-4269-9CAF-E6D39209F5E7Q33835940-0AB27AE1-E500-4029-8F1D-C49B683FB990Q33999613-5A8E2085-C4B7-4710-997E-CC54844FB4D5Q35092867-6CDD80EF-2752-4623-AFE6-0E721952951AQ35516989-D029ECFE-7F03-40D5-BC09-C2716B7C4C0CQ35556009-6BE04472-3287-417D-84CA-3714CF93FF6CQ35765050-FFAD1F6E-82F3-45AD-A4CD-213B4BF24B5FQ35832730-29507BF6-1F3B-40E6-BD15-AD8A7F59F6B8Q36001865-7E198428-414C-4E65-8CB4-5683718A34F6Q36422133-F3CB5CFB-4B5D-48CC-8F8F-29BDD5D7BF75Q36522664-CAE41B03-92D8-4E9D-9696-211F43717250Q36813399-A9C5DE16-6F5C-4502-8826-C98A5D09533CQ37690497-A7202503-F9EA-4D73-82AB-0866987CE9B2Q37773233-F2010D4C-2676-4551-BAB3-7DE54E39B0A6Q38128799-5345D435-5331-41EF-BE39-861F21974904Q38262169-F9F9EEE4-7D52-411F-8F28-934A38F02EE5Q38863259-1BE587A9-1951-4BBA-A7EC-0A5FB0D70998Q38880705-BCE716DE-D965-4FBD-9CBF-DCC732480D25Q38894583-80111DA6-9B85-4E08-94DD-F976B89CA637Q38898730-F4E6E03E-7160-4B5A-8931-14A19470469BQ38924849-B10730A8-C165-428D-A055-811D049FEFC1Q39096815-AE9DE6BE-1703-4C73-B78B-A5BC01F3E809Q39147176-8A321FBA-584A-4CEB-96B9-383E44D52350Q39171333-B3FE40F0-5CF7-4DFB-BED6-4E4D641EAC18Q39182385-1AF73C86-767C-477C-B656-CFDF4EB9DC96Q39545923-F6ECA1DA-A26D-475F-A254-95201A0E6061Q39763785-814A4A74-893C-43F7-B2BE-08FD6CB58EE1Q41001279-035AA73D-8954-4068-AA55-B8228C559237Q41082186-A6E77992-23E5-426C-BE50-58285C690666Q41170711-F76A4E64-D5EB-4C6F-8F76-3BCF8D432EE1Q41695126-DA927785-4F2B-4139-9FEE-AE69079D483CQ42240087-71489AB2-D45C-416E-8EFF-3D9325BD3F2CQ42978370-19ED125C-C6D2-47CB-9F0D-8E6B36E4216CQ43732127-B772D88A-B329-403F-9E4C-0AB338499C68Q44141078-89546671-B343-43FE-B894-0BE1109EE389Q45348360-87D33456-526B-48D1-A023-7B7C52CEEFD5
P2860
Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.
@en
Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.
@nl
type
label
Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.
@en
Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.
@nl
prefLabel
Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.
@en
Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.
@nl
P2093
P1433
P1476
Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome
@en
P2093
I Yamashita
R Moriuchi
S Katamine
P304
P356
10.1016/S0140-6736(94)90630-0
P407
P50
P577
1994-10-01T00:00:00Z